variable_id,variable_label_from_data_file,label,derived_var_label,desc,form,form_id
ae_desc,,Description of adverse event:,,,Adverse Events,adverse_events
ae_dt,,Day of adverse event:,,,Adverse Events,adverse_events
ae_id,,AE identifier,,,Adverse Events,adverse_events
ae_outcome,,What was the final outcome of the adverse event?,,,Adverse Events,adverse_events
ae_recdt,,Day of recovery:,,,Adverse Events,adverse_events
ae_reldrug,,Was the adverse event related to study drug?,,,Adverse Events,adverse_events
ae_serious,,Was the adverse event serious?,,,Adverse Events,adverse_events
ae_status,,What was the status of the adverse event at the time of the initial AE report?,,,Adverse Events,adverse_events
ae_tm,,Time of adverse event:,,,Adverse Events,adverse_events
ae_unexpected,,Was the adverse event unexpected (not listed in the investigator brochure or protocol)?,,,Adverse Events,adverse_events
ae_userterm,,COSTART term: [ lookup tool ],,,Adverse Events,adverse_events
bl_age,,Age (patient must be at least 18 years of age),,,Demographics and Enrollment,demographics_and_enrollment
bl_ekgdt,,What was the day of the EKG prior to randomization?,,,Demographics and Enrollment,demographics_and_enrollment
bl_ekgqtc,,What was the QTc on the EKG prior to randomization? (ms),,,Demographics and Enrollment,demographics_and_enrollment
bl_ekgtm,,What was the time of the EKG prior to randomization?,,,Demographics and Enrollment,demographics_and_enrollment
bl_ethnic,,Ethnicity,,,Demographics and Enrollment,demographics_and_enrollment
bl_height,,Height (cm),,,Demographics and Enrollment,demographics_and_enrollment
bl_hospadmdt,,Day of presentation to the study hospital,,,Demographics and Enrollment,demographics_and_enrollment
bl_hospadmtm,,Time of presentation to the study hospital,,,Demographics and Enrollment,demographics_and_enrollment
bl_prehosp,,Source of presentation to study hospital (select one),,,Demographics and Enrollment,demographics_and_enrollment
bl_race___1,,Race (Check all that apply) (choice=Black or African American),,,Demographics and Enrollment,demographics_and_enrollment
bl_race___5,,Race (Check all that apply) (choice=White or Caucasian),,,Demographics and Enrollment,demographics_and_enrollment
bl_race___6,,Race (Check all that apply) (choice=Other),,,Demographics and Enrollment,demographics_and_enrollment
bl_race___othcat,,Race (Check all that apply) (choice=American Indian or Alaska Native/Asian/Native Hawaiian or Other Pacific Islander),,,Demographics and Enrollment,demographics_and_enrollment
bl_randloc,,Location at randomization,,,Demographics and Enrollment,demographics_and_enrollment
bl_sex,,Sex,,,Demographics and Enrollment,demographics_and_enrollment
bl_symptomdt,,Day of symptom onset,,,Demographics and Enrollment,demographics_and_enrollment
bl_weight,,Weight (kg),,,Demographics and Enrollment,demographics_and_enrollment
charl_asthma,,Asthma,,,Demographics and Enrollment,demographics_and_enrollment
charl_cad,,Coronary artery disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_cerebvasc,,Cerebrovascular disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_congheart,,Congestive heart failure,,,Demographics and Enrollment,demographics_and_enrollment
charl_contis,,Connective tissue disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_copd,,COPD,,,Demographics and Enrollment,demographics_and_enrollment
charl_dementia,,Dementia,,,Demographics and Enrollment,demographics_and_enrollment
charl_diabetes,,Diabetes mellitus (DM),,,Demographics and Enrollment,demographics_and_enrollment
charl_fatal,,Rapidly fatal disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_hemiplegia,,Hemiplegia,,,Demographics and Enrollment,demographics_and_enrollment
charl_hypertension,,History of hypertension,,,Demographics and Enrollment,demographics_and_enrollment
charl_kidney,,Moderate to severe kidney disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_leuk,,"Leukemia (AML, CML, ALL, multiple myeloma)",,,Demographics and Enrollment,demographics_and_enrollment
charl_liver,,Liver disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_lymph,,Malignant lymphoma,,,Demographics and Enrollment,demographics_and_enrollment
charl_myoinfarc,,A prior myocardial infarction,,,Demographics and Enrollment,demographics_and_enrollment
charl_perivasc,,Peripheral vascular disease,,,Demographics and Enrollment,demographics_and_enrollment
charl_tumor,,Solid tumor,,,Demographics and Enrollment,demographics_and_enrollment
charl_ulcer,,Peptic ulcer disease,,,Demographics and Enrollment,demographics_and_enrollment
chart_oxygen,,"Chronic receipt of supplemental oxygen prior to current illness Supplemental oxygen is defined as oxygen administered by nasal cannula, face mask, high-flow nasal cannula, non-invasive ventilation, or invasive ventilation.  Positive airway pressure (CPAP o",,,Demographics and Enrollment,demographics_and_enrollment
cons_certify,,"Before randomization, the enrolling investigator must certify that that all of the following are true:  Patient met all inclusion criteria Patient met no exclusion criteria Study Informed Consent Document/Form (ICD/ICF) were explained and reviewed with the",,,Eligibility Criteria,eligibility_criteria
covid_ooscale_1,,COVID Ordinal Outcomes Scale at randomization,,,Demographics and Enrollment,demographics_and_enrollment
covid_ooscale_15,,COVID Ordinal Outcomes Scale on Day 15Select the lowest value that occurred on this study day,,,Day 15 Phone Call,day_15_phone_call
covid_ooscale_2,,COVID Ordinal Outcomes Scale on Day 2Select the lowest value that occurred on this study day,,,Day 2 Assessment,day_2_assessment
covid_ooscale_29,,COVID Ordinal Outcomes Scale on Day 29Select the lowest value that occurred on this study day,,,Day 29 Phone Call,day_29_phone_call
covid_ooscale_3,,COVID Ordinal Outcomes Scale on Day 3Select the lowest value that occurred on this study day,,,Day 3 Assessment,day_3_assessment
covid_ooscale_4,,COVID Ordinal Outcomes Scale on Day 4Select the lowest value that occurred on this study day,,,Day 4 Assessment,day_4_assessment
covid_ooscale_5,,COVID Ordinal Outcomes Scale on Day 5Select the lowest value that occurred on this study day,,,Day 5 Assessment,day_5_assessment
covid_ooscale_8,,COVID Ordinal Outcomes Scale on Day 8Select the lowest value that occurred on this study day,,,Day 8 Phone Call,day_8_phone_call
d_bl_age_s,Standardized age at baseline,,Standardized age at baseline,,Form Unknown,form_unknown
d_bl_icu,Baseline ICU,,Baseline ICU,,Form Unknown,form_unknown
d_bmi,BMI,,BMI,,Form Unknown,form_unknown
d_bstatus_No02,Not on oxygen baseline,,Not on oxygen baseline,,Form Unknown,form_unknown
d_bstatus_sp02,On supplemental oxygen at baseline,,On supplemental oxygen at baseline,,Form Unknown,form_unknown
d_covid15,COVID Ordinal Outcomes Scale on Day 15 (derived),,COVID Ordinal Outcomes Scale on Day 15 (derived),,Form Unknown,form_unknown
d_covid2,COVID Ordinal Outcomes Scale on Day 2 (derived),,COVID Ordinal Outcomes Scale on Day 2 (derived),,Form Unknown,form_unknown
d_covid29,COVID Ordinal Outcomes Scale on Day 29 (derived),,COVID Ordinal Outcomes Scale on Day 29 (derived),,Form Unknown,form_unknown
d_covid3,COVID Ordinal Outcomes Scale on Day 3 (derived),,COVID Ordinal Outcomes Scale on Day 3 (derived),,Form Unknown,form_unknown
d_covid4,COVID Ordinal Outcomes Scale on Day 4 (derived),,COVID Ordinal Outcomes Scale on Day 4 (derived),,Form Unknown,form_unknown
d_covid5,COVID Ordinal Outcomes Scale on Day 5 (derived),,COVID Ordinal Outcomes Scale on Day 5 (derived),,Form Unknown,form_unknown
d_covid8,COVID Ordinal Outcomes Scale on Day 8 (derived),,COVID Ordinal Outcomes Scale on Day 8 (derived),,Form Unknown,form_unknown
d_deathday,Death day,,Death day,,Form Unknown,form_unknown
d_doses,Number of Doses Administered,,Number of Doses Administered,,Form Unknown,form_unknown
d_ecmo_death,Ecmo or Death,,Ecmo or Death,,Form Unknown,form_unknown
d_fu_days,Follow-Up Days,,Follow-Up Days,,Form Unknown,form_unknown
d_hospfreedays,Hospital Free Days,,Hospital Free Days,,Form Unknown,form_unknown
d_icufreedays,ICU Free Days,,ICU Free Days,,Form Unknown,form_unknown
d_lastalivedt,Last alive day,,Last alive day,,Form Unknown,form_unknown
d_male_sex,Sex: Male,,Sex: Male,,Form Unknown,form_unknown
d_mort15,Day 15 mortality,,Day 15 mortality,,Form Unknown,form_unknown
d_mort29,Day 29 mortality,,Day 29 mortality,,Form Unknown,form_unknown
d_onset_duration,Duration of sypmtoms prior to randomization (days),,Duration of sypmtoms prior to randomization (days),,Form Unknown,form_unknown
d_oxyfreedays,Oxygen free days,,Oxygen free days,,Form Unknown,form_unknown
d_pfratio,P/F ratio,,P/F ratio,,Form Unknown,form_unknown
d_race,Race,,Race,,Form Unknown,form_unknown
d_remd_ever,Remdesivir (ever/never),,Remdesivir (ever/never),,Form Unknown,form_unknown
d_sfratio,S/F ratio,,S/F ratio,,Form Unknown,form_unknown
d_sofa_cardio,SOFA Cardiovascular,,SOFA Cardiovascular,,Form Unknown,form_unknown
d_sofa_coag,SOFA Coagulation,,SOFA Coagulation,,Form Unknown,form_unknown
d_sofa_gcs,Total SOFA (with GCS),,Total SOFA (with GCS),,Form Unknown,form_unknown
d_sofa_gcs_s,Standardized Total SOFA with GCS at baseline,,Standardized Total SOFA with GCS at baseline,,Form Unknown,form_unknown
d_sofa_liver,SOFA Liver,,SOFA Liver,,Form Unknown,form_unknown
d_sofa_nervous,SOFA Nervous System,,SOFA Nervous System,,Form Unknown,form_unknown
d_sofa_nogcs,Total SOFA (without GCS),,Total SOFA (without GCS),,Form Unknown,form_unknown
d_sofa_renal,SOFA Renal,,SOFA Renal,,Form Unknown,form_unknown
d_sofa_resp,SOFA Respiratory,,SOFA Respiratory,,Form Unknown,form_unknown
d_time_to_recovery,Time to recovery,,Time to recovery,,Form Unknown,form_unknown
d_vasofreedays,Vasopressor Free Days,,Vasopressor Free Days,,Form Unknown,form_unknown
d_ventfreedays,Ventilator Free Days,,Ventilator Free Days,,Form Unknown,form_unknown
dose_dt_1,,Day dose 1 administered,,,Dose 1,dose_1
dose_dt_10,,Day dose 10 administered,,,Dose 10,dose_10
dose_dt_2,,Day dose 2 administered,,,Dose 2,dose_2
dose_dt_3,,Day dose 3 administered,,,Dose 3,dose_3
dose_dt_4,,Day dose 4 administered,,,Dose 4,dose_4
dose_dt_5,,Day dose 5 administered,,,Dose 5,dose_5
dose_dt_6,,Day dose 6 administered,,,Dose 6,dose_6
dose_dt_7,,Day dose 7 administered,,,Dose 7,dose_7
dose_dt_8,,Day dose 8 administered,,,Dose 8,dose_8
dose_dt_9,,Day dose 9 administered,,,Dose 9,dose_9
dose_int_1,,Hours since randomization,,,Dose 1,dose_1
dose_int_10,,Hours since last dose:,,,Dose 10,dose_10
dose_int_2,,Hours since last dose:,,,Dose 2,dose_2
dose_int_3,,Hours since last dose:,,,Dose 3,dose_3
dose_int_4,,Hours since last dose:,,,Dose 4,dose_4
dose_int_5,,Hours since last dose:,,,Dose 5,dose_5
dose_int_6,,Hours since last dose:,,,Dose 6,dose_6
dose_int_7,,Hours since last dose:,,,Dose 7,dose_7
dose_int_8,,Hours since last dose:,,,Dose 8,dose_8
dose_int_9,,Hours since last dose:,,,Dose 9,dose_9
dose_notadm_1,,Reason study drug dose 1 not administered,,,Dose 1,dose_1
dose_notadm_10,,Reason study drug dose 10 not administered,,,Dose 10,dose_10
dose_notadm_2,,Reason study drug dose 2 not administered,,,Dose 2,dose_2
dose_notadm_3,,Reason study drug dose 3 not administered,,,Dose 3,dose_3
dose_notadm_4,,Reason study drug dose 4 not administered,,,Dose 4,dose_4
dose_notadm_5,,Reason study drug dose 5 not administered,,,Dose 5,dose_5
dose_notadm_6,,Reason study drug dose 6 not administered,,,Dose 6,dose_6
dose_notadm_7,,Reason study drug dose 7 not administered,,,Dose 7,dose_7
dose_notadm_8,,Reason study drug dose 8 not administered,,,Dose 8,dose_8
dose_notadm_9,,Reason study drug dose 9 not administered,,,Dose 9,dose_9
dose_notadmoth_1,,Other reason study drug dose 1 not administered,,,Dose 1,dose_1
dose_notadmoth_10,,Other reason study drug dose 10 not administered,,,Dose 10,dose_10
dose_notadmoth_2,,Other reason study drug dose 2 not administered,,,Dose 2,dose_2
dose_notadmoth_3,,Other reason study drug dose 3 not administered,,,Dose 3,dose_3
dose_notadmoth_4,,Other reason study drug dose 4 not administered,,,Dose 4,dose_4
dose_notadmoth_5,,Other reason study drug dose 5 not administered,,,Dose 5,dose_5
dose_notadmoth_6,,Other reason study drug dose 6 not administered,,,Dose 6,dose_6
dose_notadmoth_7,,Other reason study drug dose 7 not administered,,,Dose 7,dose_7
dose_notadmoth_8,,Other reason study drug dose 8 not administered,,,Dose 8,dose_8
dose_notadmoth_9,,Other reason study drug dose 9 not administered,,,Dose 9,dose_9
dose_notadmspec_1,,Please give detailed description of why study drug dose 1 was not administered,,,Dose 1,dose_1
dose_notadmspec_10,,Please give detailed description of why study drug dose 10 was not administered,,,Dose 10,dose_10
dose_notadmspec_2,,Please give detailed description of why study drug dose 2 was not administered,,,Dose 2,dose_2
dose_notadmspec_3,,Please give detailed description of why study drug dose 3 was not administered,,,Dose 3,dose_3
dose_notadmspec_4,,Please give detailed description of why study drug dose 4 was not administered,,,Dose 4,dose_4
dose_notadmspec_5,,Please give detailed description of why study drug dose 5 was not administered,,,Dose 5,dose_5
dose_notadmspec_6,,Please give detailed description of why study drug dose 6 was not administered,,,Dose 6,dose_6
dose_notadmspec_7,,Please give detailed description of why study drug dose 7 was not administered,,,Dose 7,dose_7
dose_notadmspec_8,,Please give detailed description of why study drug dose 8 was not administered,,,Dose 8,dose_8
dose_notadmspec_9,,Please give detailed description of why study drug dose 9 was not administered,,,Dose 9,dose_9
dose_tm_1,,Time dose 1 administered,,,Dose 10,dose_10
dose_tm_10,,Time dose 10 administered,,,Dose 2,dose_2
dose_tm_2,,Time dose 2 administered,,,Dose 3,dose_3
dose_tm_3,,Time dose 3 administered,,,Dose 4,dose_4
dose_tm_4,,Time dose 4 administered,,,Dose 5,dose_5
dose_tm_5,,Time dose 5 administered,,,Dose 6,dose_6
dose_tm_6,,Time dose 6 administered,,,Dose 7,dose_7
dose_tm_7,,Time dose 7 administered,,,Dose 8,dose_8
dose_tm_8,,Time dose 8 administered,,,Dose 9,dose_9
dose_tm_9,,Time dose 9 administered,,,Dose 9,dose_9
dose_yn_1,,Was dose 1 of study medication given?Dose 1 is scheduled to be given 4 hours after randomization,,,Dose 1,dose_1
dose_yn_10,,Was dose 10 of study medication given?Dose 10 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 10,dose_19
dose_yn_2,,Was dose 2 of study medication given?Dose 2 is scheduled to be given between 8 and 16 hours after prior scheduled dose,,,Dose 2,dose_2
dose_yn_3,,Was dose 3 of study medication given?Dose 3 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 3,dose_3
dose_yn_4,,Was dose 4 of study medication given?Dose 4 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 4,dose_4
dose_yn_5,,Was dose 5 of study medication given?Dose 5 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 5,dose_5
dose_yn_6,,Was dose 6 of study medication given?Dose 6 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 6,dose_6
dose_yn_7,,Was dose 7 of study medication given?Dose 7 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 7,dose_7
dose_yn_8,,Was dose 8 of study medication given?Dose 8 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 8,dose_8
dose_yn_9,,Was dose 9 of study medication given?Dose 9 is scheduled to be given between 8 and 16 hours after prior scheduled dose.,,,Dose 9,dose_9
ekg_clindt_2,,Day of EKG or rhythm strip from which QTc was assessed,,,Day 2 Assessment,day_2_assessment
ekg_clindt_3,,Day of EKG or rhythm strip from which QTc was assessed,,,Day 3 Assessment,day_3_assessment
ekg_clindt_4,,Day of EKG or rhythm strip from which QTc was assessed,,,Day 4 Assessment,day_4_assessment
ekg_clindt_5,,Day of EKG or rhythm strip from which QTc was assessed,,,Day 5 Assessment,day_5_assessment
ekg_clindtm_5,,Time of EKG or rhythm strip from which QTc was assessed,,,Day 5 Assessment,day_5_assessment
ekg_clinobt_3,,Were any of the clinically obtained EKGs obtained between 24 and 48 hours after the first administration of the study drug?,,,Day 3 Assessment,day_3_assessment
ekg_clinqtc_2,,"Value for QTc, ms",,,Day 2 Assessment,day_2_assessment
ekg_clinqtc_3,,"Value for QTc, ms",,,Day 3 Assessment,day_3_assessment
ekg_clinqtc_4,,"Value for QTc, ms",,,Day 4 Assessment,day_4_assessment
ekg_clinqtc_5,,"Value for QTc, ms",,,Day 5 Assessment,day_5_assessment
ekg_clintm_2,,Time of EKG or rhythm strip from which QTc was assessed,,,Day 2 Assessment,day_2_assessment
ekg_clintm_3,,Time of EKG or rhythm strip from which QTc was assessed,,,Day 3 Assessment,day_3_assessment
ekg_clintm_4,,Time of EKG or rhythm strip from which QTc was assessed,,,Day 4 Assessment,day_4_assessment
ekg_clinyn_2,,Was a clinical EKG performed on this study day?,,,Day 2 Assessment,day_2_assessment
ekg_clinyn_3,,Was a clinical EKG performed on this study day?,,,Day 3 Assessment,day_3_assessment
ekg_clinyn_4,,Was a clinical EKG performed on this study day?,,,Day 4 Assessment,day_4_assessment
ekg_clinyn_5,,Was a clinical EKG performed on this study day?,,,Day 5 Assessment,day_5_assessment
ekg_studydt_3,,Day of EKG or rhythm strip from which QTc was assessed,,,Day 3 Assessment,day_3_assessment
ekg_studyno_3,,Why was an assessment of QTc not performed 24-48 hours after first administration of study drug?,,,Day 3 Assessment,day_3_assessment
ekg_studynoreas_3,,Describe why assessment of QTc was not performed at 24-48 hours after first dose of study drug,,,Day 3 Assessment,day_3_assessment
ekg_studyqtc_3,,"Value for QTc, ms",,,Day 3 Assessment,day_3_assessment
ekg_studytm_3,,Time of EKG or rhythm strip from which QTc was assessed,,,Day 3 Assessment,day_3_assessment
ekg_studyyn_3,,Was an assessment of QTc with EKG or rhythm strip performed 24-48 hours after first administration of study drug?,,,Day 3 Assessment,day_3_assessment
extract_dt,Extract day,,Extract day,,Form Unknown,form_unknown
ie_approved,,Did the treating clinicians provide permission to approach patient/LAR for informed consent discussion,,,Eligibility Criteria,eligibility_criteria
ie_arisymptoms___cou,,Which symptoms of acute respiratory infection does the patient present? (choice=Cough),,Which symptoms of acute respiratory infection does the patient present? Cough,Eligibility Criteria,eligibility_criteria
ie_arisymptoms___fev,,Which symptoms of acute respiratory infection does the patient present? (choice=Fever (> 37.5° C / 99.5° F)),,Which symptoms of acute respiratory infection does the patient present? Fever (> 37.5¡ C / 99.5¡ F),Eligibility Criteria,eligibility_criteria
ie_arisymptoms___sob,,Which symptoms of acute respiratory infection does the patient present? (choice=Shortness of breath),,Which symptoms of acute respiratory infection does the patient present? Shortness of breath,Eligibility Criteria,eligibility_criteria
ie_arisymptoms___st,,Which symptoms of acute respiratory infection does the patient present? (choice=Sore throat),,Which symptoms of acute respiratory infection does the patient present? Sore throat,Eligibility Criteria,eligibility_criteria
ie_eallergy,,"Known allergy to hydroxychloroquine, chloroquine, or amodiaquine",,,Eligibility Criteria,eligibility_criteria
ie_eari,,Symptoms of acute respiratory infection for >10 days before randomization,,,Eligibility Criteria,eligibility_criteria
ie_ebreast,,Breast feeding,,,Eligibility Criteria,eligibility_criteria
ie_echlor,,Receipt of >1 dose of hydroxychloroquine or chloroquine in the 10 days prior to randomization,,,Eligibility Criteria,eligibility_criteria
ie_econtra,,"Receipt in the 12 hours prior to randomization, or planned administration during the 5-day study period, of a contraindicated medication that treating clinicians feel cannot be substituted (any of the following):  Amiodarone Cimetidine Dofetilide Phenobarb",,,Eligibility Criteria,eligibility_criteria
ie_elate,,More than 48 hours from hospitalization,,,Eligibility Criteria,eligibility_criteria
ie_eligible,,"Patient is eligible (1=yes, 0=no)",,,Eligibility Criteria,eligibility_criteria
ie_elongqt,,Diagnosis of Long QT syndrome,,,Eligibility Criteria,eligibility_criteria
ie_enocontact,,Refusal or Iinability to be contacted on Day 15 for clinical outcome assessment if discharged prior to Day 15,,,Eligibility Criteria,eligibility_criteria
ie_enpo,,Inability to receive enteral medications,,,Eligibility Criteria,eligibility_criteria
ie_enrolled,,Was the patient enrolled?,,,Eligibility Criteria,eligibility_criteria
ie_eporphyria,,Porphyria cutanea tarda,,,Eligibility Criteria,eligibility_criteria
ie_epreg,,Pregnant,,,Eligibility Criteria,eligibility_criteria
ie_epris,,Prisoner,,,Eligibility Criteria,eligibility_criteria
ie_eqtc500,,QTc >500 ms on electrocardiogram within 72 hours prior to randomization,,,Eligibility Criteria,eligibility_criteria
ie_equipoise,,The treating clinical team does not believe equipoise exists regarding the use of hydroxychloroquine for the treatment of this patient,,,Eligibility Criteria,eligibility_criteria
ie_eseizure,,Seizure disorder,,,Eligibility Criteria,eligibility_criteria
ie_iok,,"Did the patient meet all inclusion criteria?  Age 18 years Currently hospitalized or in an emergency department with anticipated hospitalization. Symptoms of acute respiratory infection, defined as one or more of the following:  cough fever (> 37.5° C / 9",,"Did the patient meet all inclusion criteria? Age ³18 years Currently hospitalized or in an emergency department with anticipated hospitalization. Symptoms of acute respiratory infection, defined as one or more of the following: cough fever (> 37.5¡ C / 99.5¡ F) shortness of breath sore throat Laboratory- confirmed SARS-CoV-2 infection within the past 10 days or SARS-CoV-2 infection within the past 10 days or SARS-CoV-2 laboratory test result pending plus a high clinical suspicion for COVID-19 as indicated by fulfilling all of the following: Cough with duration <= 10 days Bilateral pulmonary infiltrates on chest imaging (radiograph, computed tomography or ultrasound) or new hypoxemia defined as SpO2 <= 94% on room air No alternative explanation for symptoms of acute respiratory infection",Eligibility Criteria,eligibility_criteria
ie_iok_v2,,"Did the patient meet all inclusion criteria?Age 18 yearsCurrently hospitalized or in an emergency department with anticipated hospitalization.Symptoms of acute respiratory infection, defined as one or more of the following: coughfever (> 37.5° C / 99.5° F",,"Did the patient meet all inclusion criteria?Age ³18 yearsCurrently hospitalized or in an emergency department with anticipated hospitalization.Symptoms of acute respiratory infection, dened as one or more of the following: coughfever (> 37.5¡ C / 99.5¡ F)shortness of breathsore throatLaboratory- conrmed SARS-CoV-2 infection within the past 10 days prior to randomization. ",Eligibility Criteria,eligibility_criteria
ie_labstatus,,Specify the laboratory confirmation status:,,,Eligibility Criteria,eligibility_criteria
ie_nene,,Not excluded but not enrolled,,,Eligibility Criteria,eligibility_criteria
ie_nenespec,,Please explain why the patient was not enrolled:,,,Eligibility Criteria,eligibility_criteria
ie_notenrolledreas,,Reason not enrolled?,,,Eligibility Criteria,eligibility_criteria
ie_notenrolledreas_other,,If Other please describe:,,,Eligibility Criteria,eligibility_criteria
ie_prevenroll,,Previous enrollment in this trial,,,Eligibility Criteria,eligibility_criteria
ie_version,,IE form version,,,Eligibility Criteria,eligibility_criteria
ih_aeassess_2,,"Adverse Event Assessment Study Day 2On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 2 Assessment,day_2_assessment
ih_aeassess_3,,"Adverse Event Assessment Study Day 3On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 3 Assessment,day_3_assessment
ih_aeassess_4,,"Adverse Event Assessment Study Day 4On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 4 Assessment,day_4_assessment
ih_aeassess_5,,"Adverse Event Assessment Study Day 5On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 5 Assessment,day_5_assessment
ih_aeassessreas_2,,Why were AEs not assessed?,,,Day 2 Assessment,day_2_assessment
ih_aeassessreas_3,,Why were AEs not assessed?,,,Day 3 Assessment,day_3_assessment
ih_aeassessreas_4,,Why were AEs not assessed?,,,Day 4 Assessment,day_4_assessment
ih_aeassessreas_5,,Why were AEs not assessed?,,,Day 5 Assessment,day_5_assessment
ih_contra_2,,Contraindicated Medications Day 2Review the electronic health record for orders or administration of the following medications that are considered CONTRAINDICATED:amiodaronechloroquinecimetidinedofetilidephenobarbitalphenytoinsotalol,,,Day 2 Assessment,day_2_assessment
ih_contra_3,,Contraindicated Medications Day 3Review the electronic health record for orders or administration of the following medications that are considered CONTRAINDICATED:amiodaronechloroquinecimetidinedofetilidephenobarbitalphenytoinsotalol,,,Day 3 Assessment,day_3_assessment
ih_contra_4,,Contraindicated Medications Day 4Review the electronic health record for orders or administration of the following medications that are considered CONTRAINDICATED:amiodaronechloroquinecimetidinedofetilidephenobarbitalphenytoinsotalol,,,Day 4 Assessment,day_4_assessment
ih_contra_5,,Contraindicated Medications Day 5Review the electronic health record for orders or administration of the following medications that are considered CONTRAINDICATED:amiodaronechloroquinecimetidinedofetilidephenobarbitalphenytoinsotalol,,,Day 5 Assessment,day_5_assessment
ih_contraoccur_2,,Describe what occurred when it was discovered that patient was receiving study drug and a CONTRAINDICATED medication,,,Day 2 Assessment,day_2_assessment
ih_contraoccur_3,,Describe what occurred when it was discovered that patient was receiving study drug and a CONTRAINDICATED medication,,,Day 3 Assessment,day_3_assessment
ih_contraoccur_4,,Describe what occurred when it was discovered that patient was receiving study drug and a CONTRAINDICATED medication,,,Day 4 Assessment,day_4_assessment
ih_contraoccur_5,,Describe what occurred when it was discovered that patient was receiving study drug and a CONTRAINDICATED medication,,,Day 5 Assessment,day_5_assessment
ih_interact_2,,"Medication Interaction Day 2On this study day, review the electronic health record for orders or administration of the following medications that are considered to have a potential interaction with study drug:ampicillinantacidscyclosporinedigoxinflecainide",,,Day 2 Assessment,day_2_assessment
ih_interact_3,,"Medication Interaction Day 2On this study day, review the electronic health record for orders or administration of the following medications that are considered to have a potential interaction with study drug:ampicillinantacidscyclosporinedigoxinflecainide",,,Day 3 Assessment,day_3_assessment
ih_interact_4,,"Medication Interaction Day 4On this study day, review the electronic health record for orders or administration of the following medications that are considered to have a potential interaction with study drug:ampicillinantacidscyclosporinedigoxinflecainide",,,Day 4 Assessment,day_4_assessment
ih_interact_5,,"Medication Interaction Day 5On this study day, review the electronic health record for orders or administration of the following medications that are considered to have a potential interaction with study drug:ampicillinantacidscyclosporinedigoxinflecainide",,,Day 5 Assessment,day_5_assessment
ih_interactoccur_2,,Describe what occurred when it was discovered that patient was receiving study drug and a medication with a potential interaction,,,Day 2 Assessment,day_2_assessment
ih_interactoccur_3,,Describe what occurred when it was discovered that patient was receiving study drug and a medication with a potential interaction,,,Day 3 Assessment,day_3_assessment
ih_interactoccur_4,,Describe what occurred when it was discovered that patient was receiving study drug and a medication with a potential interaction,,,Day 4 Assessment,day_4_assessment
ih_interactoccur_5,,Describe what occurred when it was discovered that patient was receiving study drug and a medication with a potential interaction,,,Day 5 Assessment,day_5_assessment
ih_safeassess_2,,"Safety Outcome Assessment Study Day 2On this study day, study personnel assessed for the occurrence of safety outcomes that might prompt discontinuation of the study drug (and if found recorded in Safety Outcomes CRF).",,,Day 2 Assessment,day_2_assessment
ih_safeassess_3,,"Safety Outcome Assessment Study Day 3On this study day, study personnel assessed for the occurrence of safety outcomes that might prompt discontinuation of the study drug (and if found recorded in Safety Outcomes CRF).",,,Day 3 Assessment,day_3_assessment
ih_safeassess_4,,"Safety Outcome Assessment Study Day 4On this study day, study personnel assessed for the occurrence of safety outcomes that might prompt discontinuation of the study drug (and if found recorded in Safety Outcomes CRF).",,,Day 4 Assessment,day_4_assessment
ih_safeassess_5,,"Safety Outcome Assessment Study Day 5On this study day, study personnel assessed for the occurrence of safety outcomes that might prompt discontinuation of the study drug (and if found recorded in Safety Outcomes CRF).",,,Day 5 Assessment,day_5_assessment
ih_safeassessreas_2,,Why were safety outcomes not assessed?,,,Day 2 Assessment,day_2_assessment
ih_safeassessreas_3,,Why were safety outcomes not assessed?,,,Day 3 Assessment,day_3_assessment
ih_safeassessreas_4,,Why were safety outcomes not assessed?,,,Day 4 Assessment,day_4_assessment
ih_safeassessreas_5,,Why were safety outcomes not assessed?,,,Day 5 Assessment,day_5_assessment
ih_yn_2,,"Was the patient located in the study hospital at any time on study day 2 (i.e., admitted, inpatient)?",,,Day 2 Assessment,day_2_assessment
ih_yn_3,,"Was the patient located in the study hospital at any time on study day 3 (i.e., admitted, inpatient)?",,,Day 3 Assessment,day_3_assessment
ih_yn_4,,"Was the patient located in the study hospital at any time on study day 4 (i.e., admitted, inpatient)?",,,Day 4 Assessment,day_4_assessment
ih_yn_5,,"Was the patient located in the study hospital at any time on study day 5 (i.e., admitted, inpatient)?",,,Day 5 Assessment,day_5_assessment
iho_aboth,,Did the patient receive any antibiotics (other than azithromycin) between randomization and day 8?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_abothdt,,Day of first dose of first other antibiotic after randomization,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_abothtm,,Time of first dose of first other antibiotic after randomization,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_adenovir,,Other acute viral infection: Adenovirus,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_adenovirsrc,,Adenovirus specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_avoth,,Did the patient receive any other antiviral between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_avothdt,,Day of first dose of other antiviral,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_avothspec,,Name of first other antiviral,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_avothtm,,Time of first dose of other antiviral,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_azithro,,Did the patient receive Azithromycin between randomization and day 8?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_azithrodt,,Day of first dose of Azithromycin,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_azithrotm,,Time of first dose of Azithromycin,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultdt,,Day first positive blood culture collected:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___1,,Organisms identified in first positive blood culture (choice=Acinetobacter baumanii),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___10,,Organisms identified in first positive blood culture (choice=Lactobacillus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___11,,Organisms identified in first positive blood culture (choice=Micrococcus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___12,,Organisms identified in first positive blood culture (choice=Proteus mirabilis),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___13,,Organisms identified in first positive blood culture (choice=Pseudomonas aeruginosa),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___14,,Organisms identified in first positive blood culture (choice=Serratia marcenscens),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___15,,Organisms identified in first positive blood culture (choice=Staphylococcus aureus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___16,,Organisms identified in first positive blood culture (choice=Stenotrophomonas maltophilia),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___17,,Organisms identified in first positive blood culture (choice=Streptococcus pneumoniae),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___18,,Organisms identified in first positive blood culture (choice=Viridans group streptococci),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___19,,Organisms identified in first positive blood culture (choice=Other),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___2,,Organisms identified in first positive blood culture (choice=Bacillus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___3,,Organisms identified in first positive blood culture (choice=beta-hemolytic streptococci),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___4,,Organisms identified in first positive blood culture (choice=Coagulase-negative staphylococci),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___5,,Organisms identified in first positive blood culture (choice=Corynebacterium),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___6,,Organisms identified in first positive blood culture (choice=Enterobacter cloacae),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___7,,Organisms identified in first positive blood culture (choice=Enterococcus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___8,,Organisms identified in first positive blood culture (choice=Escheria coli),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorg___9,,Organisms identified in first positive blood culture (choice=Klebsiella pneumoniae),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultorgspec,,Other organisms identified in first positive blood culture,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bculttm,,Time first positive blood culture collected:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_bcultyn,,Were any blood cultures drawn between hospital presentation and study day 7 positive?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_chlor,,Did the patient receive chloroquine between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_chlordt,,Day of first chloroquine dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_chlortm,,Time of first chloroquine dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_conpasdt,,Day patient first received convalescent plasma:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_conpastm,,Time patient first received convalescent plasma:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_conplas,,Did the patient receive convalescent plasma between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_coosptdisch,,Patient discharged home according to COVID OO Scale:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_coronaviroth,,"Other acute viral infection: Coronavirus OC43, NL63, 229E, and HKU1",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_coronavirothsrc,,"Coronavirus OC43, NL63, 229E, and HKU1 specimen source",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_corticoster,,Did the patient receive corticosteroids between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_corticosterdt,,Day of first corticosteroid dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_corticostertm,,Time of first corticosteroid dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtodt_1,,Day collected (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtodt_2,,Day collected (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtodt_3,,Day collected (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtodt_4,,Day collected (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtotm_1,,Time collected (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtotm_2,,Time collected (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtotm_3,,Time collected (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtotm_4,,Time collected (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrdt_1,,Day resulted (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrdt_2,,Day resulted (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrdt_3,,Day resulted (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrdt_4,,Day resulted (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtres_1,,First SARS-CoV-2 result,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtres_2,,Second SARS-CoV-2 result,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtres_3,,Third SARS-CoV-2 result,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtres_4,,Fourth SARS-CoV-2 result,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtresspec_1,,Other SARS-CoV-2 result (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtresspec_2,,Other SARS-CoV-2 result (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtresspec_3,,Other SARS-CoV-2 result (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtresspec_4,,Other SARS-CoV-2 result (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrtm_1,,Time resulted (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrtm_2,,Time resulted (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrtm_3,,Time resulted (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtrtm_4,,Time resulted (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrc_1,,Source of specimen (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrc_2,,Source of specimen (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrc_3,,Source of specimen (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrc_4,,Source of specimen (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrcspec_1,,Other specimen source (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrcspec_2,,Other specimen source (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrcspec_3,,Other specimen source (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtsrcspec_4,,Other specimen source (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttype_1,,Type of first SARS-CoV-2 test,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttype_2,,Type of second SARS-CoV-2 test,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttype_3,,Type of third SARS-CoV-2 test,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttype_4,,Type of fourth SARS-CoV-2 test,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttypespec_1,,Other test type (1),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttypespec_2,,Other test type (2),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttypespec_3,,Other test type (3),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidttypespec_4,,Other test type (4),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtyn_2,,Was an additional SARS-CoV2 test performed?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtyn_3,,Was an additional SARS-CoV2 test performed?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_covidtyn_4,,Was an additional SARS-CoV2 test performed?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dischdest,,Patient destination at discharge:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dischdt,,Hospital Discharge Day,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dischtm,,Hospital Discharge Time,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dischyn,,Was the patient discharged alive from the hospital on or before study day 29?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dvt,,"Was the patient diagnosed with a deep venous thrombosis (DVT) between randomization and the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dvtdt,,Day of first study demonstrating DVT:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_dvttm,,Time of first study demonstrating DVT:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_ecmo,,"Did the patient receive extracorporeal membrane oxygenation (ECMO) between randomization and the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_ecmodiscon,,"Was the patient still receiving ECMO at the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_ecmodiscondt,,Day of final discontinuation of ECMO,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_ecmodiscontm,,Time of final discontinuation of ECMO,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_ecmodt,,Day ECMO first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_ecmotm,,Time ECMO first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_enterovir,,Other acute viral infection: Enterovirus,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_enterovirsrc,,Enterovirus specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_flua,,Other acute viral infection: Influenza A,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_fluasrc,,Influenza A specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_flub,,Other acute viral infection: Influenza B,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_flubsrc,,Influenza B specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hfnc,,"Did the patient receive high flow nasal cannula between randomization and the first of discharge, death, or study day 29?High flow nasal cannula refers to devices that deliver oxygen at 30 to 60 liters per minute with a titratable FiO2. Brand names include",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hfncdiscon,,"Was the patient still receiving high flow nasal cannula at the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hfncdiscondt,,Day of final discontinuation of high flow nasal cannula,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hfncdiscontm,,Time of final discontinuation of high flow nasal cannula,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hfncdt,,Day high flow nasal cannula first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hfnctm,,Time high flow nasal cannula first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hydroxychlor,,Did the patient receive open label hydroxychloroquine between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hydroxychlordt,,Day of first hydroxychloroquine dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_hydroxychlortm,,Time of first hydroxychloroquine dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_icu,,"Was the patient ever located in an ICU between randomization and the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_icudisch,,"Was patient located in an ICU at the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_icudischdt,,Day of final ICU discharge,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_icudischtm,,Time of final ICU discharge,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_icudt,,Day of ICU admission,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_icutm,,Time of ICU admission,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immglob,,Did the patient receive SARS-CoV-2 hyperimmune globulin between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immglobdt,,Day patient first received SARS-CoV-2 hyperimmune globulin:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immglobtm,,Time patient first received SARS-CoV-2 hyperimmune globulin:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immoth,,Did the patient receive any other immunomodulating medication between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immothdt,,Day of first other immunomodulating medications,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immothspec,,Name of other immunomodulating medications,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_immothtm,,Time of first other immunomodulating medications,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_imv,,"Did the patient receive invasive mechanical ventilation between randomization and the first of discharge, death, or study day 29?Invasive mechanical ventilation refers to ventilation via endotracheal tube or tracheostomy",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_imvdiscon,,"Was the patient still receiving invasive mechanical ventilation at the first of discharge, death or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_imvdiscondt,,Day of final discontinuation of invasive mechanical ventilation,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_imvdiscontm,,Time of final discontinuation of invasive mechanical ventilation,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_imvdt,,Day invasive mechanical ventilation received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_imvtm,,Time invasive mechanical ventilation received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_interferon,,Did the patient receive Interferon  between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_interferondt,,Day of first Interferon ß dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_interferontm,,Time of first Interferon dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_lopinavir,,Did the patient receive lopinavir/ritonavir between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_lopinavirdt,,Day of first lopinavir/ritonavir dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_lopinavirtm,,Time of first lopinavir/ritonavir dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_metapneumovir,,Other acute viral infection: Human metapneumovirus,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_metapneumovirsrc,,Human metapneumovirus specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_monocanti,,Did the patient receive monoclonal antibodies between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_monocantidt,,Day patient first received monoclonal antibodies:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_monocantitm,,Time patient first received monoclonal antibodies:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_niv,,"Did the patient receive non-invasive ventilation (bipap) between randomization and the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_nivdiscon,,"Was the patient still receiving non-invasive ventilation at the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_nivdiscondt,,Day of final discontinuation,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_nivdiscontm,,Time of final discontinuation,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_nivdt,,Day non-invasive ventilation first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_nivtm,,Time non-invasive ventilation first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_oxy,,"Did the patient receive oxygen between randomization and the first of discharge, death, or study day 29?  Supplemental oxygen is defined as oxygen administered by nasal cannula, face mask, high-flow nasal cannula, non-invasive ventilation, or invasive vent",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_oxydiscon,,"Was the patient still receiving oxygen at the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_oxydiscondt,,Day of final discontinuation of oxygen,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_oxydiscontm,,Time of final discontinuation of oxygen,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_oxydt,,Day oxygen first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_oxytm,,Time oxygen first received,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_paraflu,,Other acute viral infection: Parainfluenza,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_paraflusrc,,Parainfluenza specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_pe,,"Was the patient diagnosed with a pulmonary embolism (PE) between randomization and the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_pedt,,Day of first study demonstrating PE:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_petm,,Time of first study demonstrating PE:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultdt,,Day first positive culture collected:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___1,,Organisms identified in first positive respiratory culture: (choice=Acinetobacter baumanii),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___10,,Organisms identified in first positive respiratory culture: (choice=Lactobacillus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___11,,Organisms identified in first positive respiratory culture: (choice=Micrococcus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___12,,Organisms identified in first positive respiratory culture: (choice=Proteus mirabilis),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___13,,Organisms identified in first positive respiratory culture: (choice=Pseudomonas aeruginosa),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___14,,Organisms identified in first positive respiratory culture: (choice=Serratia marcenscens),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___15,,Organisms identified in first positive respiratory culture: (choice=Staphylococcus aureus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___16,,Organisms identified in first positive respiratory culture: (choice=Stenotrophomonas maltophilia),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___17,,Organisms identified in first positive respiratory culture: (choice=Streptococcus pneumoniae),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___18,,Organisms identified in first positive respiratory culture: (choice=Viridans group streptococci),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___19,,Organisms identified in first positive respiratory culture: (choice=Other),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___2,,Organisms identified in first positive respiratory culture: (choice=Bacillus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___3,,Organisms identified in first positive respiratory culture: (choice=beta-hemolytic streptococci),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___4,,Organisms identified in first positive respiratory culture: (choice=Coagulase-negative staphylococci),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___5,,Organisms identified in first positive respiratory culture: (choice=Corynebacterium),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___6,,Organisms identified in first positive respiratory culture: (choice=Enterobacter cloacae),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___7,,Organisms identified in first positive respiratory culture: (choice=Enterococcus),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___8,,Organisms identified in first positive respiratory culture: (choice=Escheria coli),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultorg___9,,Organisms identified in first positive respiratory culture: (choice=Klebsiella pneumoniae),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultsrc,,Source of Culture,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rculttm,,Time first positive culture collected:,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rcultyn,,"Were any bacterial respiratory cultures (sputum, tracheal aspirate, or bronchoalveolar lavage) obtained between hospital presentation and study day 7 positive?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_remdesivir,,Did the patient receive remdesivir between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_remdesivirdt,,Day of first remdesivir dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_remdesivirtm,,Time of first remdesivir dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rhinovir,,Other acute viral infection: Rhinovirus,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rhinovirsrc,,Rhinovirus specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rsv,,Other acute viral infection: Respiratory Syncytial Virus,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_rsvsrc,,Respiratory Syncytial Virus specimen source,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_sarilumab,,Did the patient receive sarilumab between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_sarilumabdt,,Day of first sarilumab dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_sarilumabtm,,Time of first sarilumab dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_tocilizumab,,Did the patient receive tocilizumab between randomization and hospital discharge?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_tocilizumabdt,,Day of first tocilizumab dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_tocilizumabtm,,Time of first tocilizumab dose,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasop,,"Did the patient receive intravenous vasopressors or inotropes between randomization and the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasopdiscon,,"Was the patient still receiving vasopressors at the first of discharge, death, or study day 29?",,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasopdiscondt,,Day of final discontinuation of vasopressors/inotropes,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasopdiscontm,,Time of final discontinuation of vasopressors/inotropes,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasopdt,,Day of first receipt of vasopressors,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptm,,Time of first receipt of vasopressors,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___1,,Check all vasopressors and inotropes the patient received (choice=Norepinephrine),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___2,,Check all vasopressors and inotropes the patient received (choice=Epinephrine),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___3,,Check all vasopressors and inotropes the patient received (choice=Vasopressin),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___4,,Check all vasopressors and inotropes the patient received (choice=Phenylephrine),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___5,,Check all vasopressors and inotropes the patient received (choice=Angiotensin II),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___6,,Check all vasopressors and inotropes the patient received (choice=Dobutamine),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___7,,Check all vasopressors and inotropes the patient received (choice=Dopamine),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_vasoptype___8,,Check all vasopressors and inotropes the patient received (choice=Milrinone),,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
iho_virinfyn,,Was another acute viral infection identified by clinical testing OTHER THAN SARS-CoV-2?,,,Inhospital Medications Microbiology Outcomes,inhospital_medications_microbiology_outcomes
img_ardsdt,,Day patient first documented as having bilateral opacities/infiltrates:,,,In-hospital Imaging,inhospital_imaging
img_blards,,"Using all available imaging, was the patient noted to have bilateral opacities/infiltrates that were not fully explained by effusions, lobar/lung collapse, nodules, cardiac failure or fluid overload prior to randomization?",,,In-hospital Imaging,inhospital_imaging
img_blardsclin,,"Did patient meet clinical criteria for ARDS at the time of randomization?(< 1 week of symptoms, not explained by cardiac failure, and P/F ratio < 300 or equivalent S/F ratio)",,,In-hospital Imaging,inhospital_imaging
img_ih,,Was any chest imaging available between randomization and day 8?,,,In-hospital Imaging,inhospital_imaging
img_ihards,,"Using all available imaging, was the patient noted to have bilateral opacities/infiltrates that were not fully explained by effusions, lobar/lung collapse, nodules, cardiac failure or fluid overload between randomization and day 8?",,,In-hospital Imaging,inhospital_imaging
img_ihardsclin,,"Did patient meet clinical criteria for ARDS between randomization and day 8?(< 1 week of symptoms, not explained by cardiac failure, and P/F ratio < 300 or equivalent S/F ratio)",,,In-hospital Imaging,inhospital_imaging
img_ihtype___1,,Type of chest imaging reviewed (choice=Chest radiogaph (X-ray)),,,In-hospital Imaging,inhospital_imaging
img_ihtype___2,,Type of chest imaging reviewed (choice=Computed Tomography (CT Chest)),,,In-hospital Imaging,inhospital_imaging
img_ihtype___3,,Type of chest imaging reviewed (choice=Other),,,In-hospital Imaging,inhospital_imaging
img_ihtypespec,,Describe other type(s) of chest imaging that was obtained,,,In-hospital Imaging,inhospital_imaging
img_prerand,,Was any chest imaging available in the 48 hours prior to randomization?,,,In-hospital Imaging,inhospital_imaging
img_prerandtype___1,,Type of chest imaging reviewed (choice=Chest radiogaph (X-ray)),,,In-hospital Imaging,inhospital_imaging
img_prerandtype___2,,Type of chest imaging reviewed (choice=Computed Tomography (CT Chest)),,,In-hospital Imaging,inhospital_imaging
img_prerandtype___3,,Type of chest imaging reviewed (choice=Other),,,In-hospital Imaging,inhospital_imaging
img_prerandtypespec,,Describe other type(s) of chest imaging that was obtained,,,In-hospital Imaging,inhospital_imaging
intervalname,,,,,Form Unknown,form_unknown
labs_albuminl_1,,Lowest albumin (g/dL) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_albuminl_2,,Lowest albumin (g/dL) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_albuminl_3,,Lowest albumin (g/dL) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_albuminl_4,,Lowest albumin (g/dL) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_albuminl_5,,Lowest albumin (g/dL) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_alph_1,,Highest ALP - Alkaline Phosphatase (IU/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_alph_2,,Highest ALP - Alkaline Phosphatase (IU/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_alph_3,,Highest ALP - Alkaline Phosphatase (IU/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_alph_4,,Highest ALP - Alkaline Phosphatase (IU/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_alph_5,,Highest ALP - Alkaline Phosphatase (IU/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_alth_1,,Highest ALT - Alanine aminotransferase (units per liter) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_alth_2,,Highest ALT - Alanine aminotransferase (units per liter) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_alth_3,,Highest ALT - Alanine aminotransferase (units per liter) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_alth_4,,Highest ALT - Alanine aminotransferase (units per liter) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_alth_5,,Highest ALT - Alanine aminotransferase (units per liter) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_asth_1,,Highest AST - Aspartate aminotransferase (units per liter) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_asth_2,,Highest AST - Aspartate aminotransferase (units per liter) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_asth_3,,Highest AST - Aspartate aminotransferase (units per liter) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_asth_4,,Highest AST - Aspartate aminotransferase (units per liter) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_asth_5,,Highest AST - Aspartate aminotransferase (units per liter) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_bicarbonateh_1,,Highest bicarbonate (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_bicarbonateh_2,,Highest bicarbonate (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_bicarbonateh_3,,Highest bicarbonate (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_bicarbonateh_4,,Highest bicarbonate (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_bicarbonateh_5,,Highest bicarbonate (mEq/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_bicarbonatel_1,,Lowest bicarbonate (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_bicarbonatel_2,,Lowest bicarbonate (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_bicarbonatel_3,,Lowest bicarbonate (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_bicarbonatel_4,,Lowest bicarbonate (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_bicarbonatel_5,,Lowest bicarbonate (mEq/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_bunh_1,,Highest BUN - Blood Urea Nitrogen (mg/dL) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_bunh_2,,Highest BUN - Blood Urea Nitrogen (mg/dL) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_bunh_3,,Highest BUN - Blood Urea Nitrogen (mg/dL) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_bunh_4,,Highest BUN - Blood Urea Nitrogen (Day 4),,,Day 4 Assessment,day_4_assessment
labs_bunh_5,,Highest BUN - Blood Urea Nitrogen (mg/dL) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_chlorideh_1,,Highest chloride (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_chlorideh_2,,Highest chloride (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_chlorideh_3,,Highest chloride (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_chlorideh_4,,Highest chloride (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_chlorideh_5,,Highest chloride (mEq/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_creath_2,,Highest creatinine (mg/dL) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_creath_4,,Highest creatinine (mg/dL) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_creath_5,,Highest creatinine (mg/dL) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_hemol_1,,Lowest hemoglobin (g/dl) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_hemol_2,,Lowest hemoglobin (g/dl) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_hemol_3,,Lowest hemoglobin (g/dl) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_hemol_4,,Lowest hemoglobin (g/dl) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_hemol_5,,Lowest hemoglobin (g/dl) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_inrh_2,,Highest INR - International Normalized Ratio (Day 2),,,Day 2 Assessment,day_2_assessment
labs_inrh_4,,Highest INR - International Normalized Ratio (Day 4),,,Day 4 Assessment,day_4_assessment
labs_inrh_5,,Highest INR - International Normalized Ratio (Day 5),,,Day 5 Assessment,day_5_assessment
labs_noreas_1,,"If no, why not? (Day 1)",,,Demographics and Enrollment,demographics_and_enrollment
labs_noreas_2,,"If no, why? (Day 2)",,,Day 2 Assessment,day_2_assessment
labs_noreas_3,,"If no, why? (Day 3)",,,Day 3 Assessment,day_3_assessment
labs_noreas_4,,"If no, why? (Day 4)",,,Day 4 Assessment,day_4_assessment
labs_noreas_5,,"If no, why? (Day 5)",,,Day 5 Assessment,day_5_assessment
labs_plateletl_2,,Lowest platelet count (/mm3; in thousands) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_plateletl_4,,Lowest platelet count (/mm3; in thousands) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_plateletl_5,,Lowest platelet count (Day 5),,,Day 5 Assessment,day_5_assessment
labs_potassiumh_1,,Highest potassium (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_potassiumh_2,,Highest potassium (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_potassiumh_3,,Highest potassium (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_potassiumh_4,,Highest potassium (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_potassiumh_5,,Highest potassium (mEq/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_potassiuml_1,,Lowest potassium (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_potassiuml_2,,Lowest potassium (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_potassiuml_3,,Lowest potassium (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_potassiuml_4,,Lowest potassium (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_potassiuml_5,,Lowest potassium (mEq/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_ptth_1,,Highest PTT - Partial Thromboplastin Time (seconds) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_ptth_2,,Highest PTT - Partial Thromboplastin Time (seconds) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_ptth_3,,Highest PTT - Partial Thromboplastin Time (seconds) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_ptth_4,,Highest PTT - Partial Thromboplastin Time (seconds) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_ptth_5,,Highest PTT - Partial Thromboplastin Time (seconds) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_sodiumh_1,,Highest sodium (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_sodiumh_2,,Highest sodium (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_sodiumh_3,,Highest sodium (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_sodiumh_4,,Highest sodium (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_sodiumh_5,,Highest sodium (mEq/L) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_sodiuml_1,,Lowest sodium (mEq/L) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_sodiuml_2,,Lowest sodium (mEq/L) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_sodiuml_3,,Lowest sodium (mEq/L) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_sodiuml_4,,Lowest sodium (mEq/L) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_sodiuml_5,,Lowest sodium (mEq/L)  (Day 5),,,Day 5 Assessment,day_5_assessment
labs_totbilih_2,,Highest total bilirubin (mg/dL) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_totbilih_4,,Highest total bilirubin (mg/dL) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_totbilih_5,,Highest total bilirubin (mg/dL) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_troph_1,,Highest troponin (mg/dL) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_troph_2,,Highest troponin (mg/dL) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_troph_3,,Highest troponin (mg/dL) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_troph_4,,Highest troponin (mg/dL) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_troph_5,,Highest troponin (mg/dL) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_wbch_1,,Highest white blood cell count (/mm3) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_wbch_2,,Highest white blood cell count (/mm3) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_wbch_3,,Highest white blood cell count (/mm3) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_wbch_4,,Highest white blood cell count (/mm3) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_wbch_5,,Highest white blood cell count (/mm3) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_wbcl_1,,Lowest white blood cell count (/mm3) (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_wbcl_2,,Lowest white blood cell count (/mm3) (Day 2),,,Day 2 Assessment,day_2_assessment
labs_wbcl_3,,Lowest white blood cell count (/mm3) (Day 3),,,Day 3 Assessment,day_3_assessment
labs_wbcl_4,,Lowest white blood cell count (/mm3) (Day 4),,,Day 4 Assessment,day_4_assessment
labs_wbcl_5,,Lowest white blood cell count (/mm3) (Day 5),,,Day 5 Assessment,day_5_assessment
labs_yn_1,,Were the daily labs available for this study day? (Day 1),,,Demographics and Enrollment,demographics_and_enrollment
labs_yn_2,,Were the daily labs available for this study day? (Day 2),,,Day 2 Assessment,day_2_assessment
labs_yn_3,,Were the daily labs available for this study day? (Day 3),,,Day 3 Assessment,day_3_assessment
labs_yn_4,,Were the daily labs available for this study day? (Day 4),,,Day 4 Assessment,day_4_assessment
labs_yn_5,,Were the daily labs available for this study day? (Day 5),,,Day 5 Assessment,day_5_assessment
new_id,,,,,Form Unknown,form_unknown
out_aeassess_15,,"Adverse Event Assessment Study Day 15On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 15 Phone Call,day_15_phone_call
out_aeassess_29,,"Adverse Event Assessment Study Day 29On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 29 Phone Call,day_29_phone_call
out_aeassess_8,,"Adverse Event Assessment Study Day 8On this study day, study personnel assessed for Adverse Events (and if found recorded AE in AE CRF).",,,Day 8 Phone Call,day_8_phone_call
out_aeassessreas_15,,Why were AEs not assessed?,,,Day 15 Phone Call,day_15_phone_call
out_aeassessreas_29,,Why were AEs not assessed?,,,Day 29 Phone Call,day_29_phone_call
out_aeassessreas_8,,Why were AEs not assessed?,,,Day 8 Phone Call,day_8_phone_call
out_dt_15,,Day that 15 day assessment was performed,,,Day 15 Phone Call,day_15_phone_call
out_dt_29,,Day that 29 day assessment was performed,,,Day 29 Phone Call,day_29_phone_call
out_dt_8,,Day that 8 day assessment was performed,,,Day 8 Phone Call,day_8_phone_call
out_oosnospec_15,,Please describe other reason why,,,Day 15 Phone Call,day_15_phone_call
out_oosnospec_29,,Please describe other reason why,,,Day 29 Phone Call,day_29_phone_call
out_oosnospec_8,,Please describe other reason why,,,Day 8 Phone Call,day_8_phone_call
out_oosyn_15,,Was information on the COVID Ordinal Outcome Scale available at 15 days?,,,Day 15 Phone Call,day_15_phone_call
out_oosyn_29,,Was information on the COVID Ordinal Outcome Scale available at 29 days?,,,Day 29 Phone Call,day_29_phone_call
out_oosyn_8,,Was information on the COVID Ordinal Outcome Scale available at 8 days?,,,Day 8 Phone Call,day_8_phone_call
out_safeassess_15,,"Safety Outcome Assessment Study Day 15On this study day, study personnel assessed for the occurrence of safety outcomes (and if found recorded in Safety Outcomes CRF).",,,Day 15 Phone Call,day_15_phone_call
out_safeassess_29,,"Safety Outcome Assessment Study Day 29On this study day, study personnel assessed for the occurrence of safety outcomes (and if found recorded in Safety Outcomes CRF).",,,Day 29 Phone Call,day_29_phone_call
out_safeassess_8,,"Safety Outcome Assessment Study Day 8On this study day, study personnel assessed for the occurrence of safety outcomes (and if found recorded in Safety Outcomes CRF).",,,Day 8 Phone Call,day_8_phone_call
out_safeassessreas_15,,Why were safety outcomes not assessed?,,,Day 15 Phone Call,day_15_phone_call
out_safeassessreas_29,,Why were safety outcomes not assessed?,,,Day 29 Phone Call,day_29_phone_call
out_safeassessreas_8,,Why were safety outcomes not assessed?,,,Day 8 Phone Call,day_8_phone_call
out_src_15,,Primary source of of day 15 information,,,Day 15 Phone Call,day_15_phone_call
out_src_29,,Primary source of of day 29 information,,,Day 29 Phone Call,day_29_phone_call
out_src_8,,Primary source of of day 8 information,,,Day 8 Phone Call,day_8_phone_call
out_srcspec_15,,Other source of day 15 information,,,Day 15 Phone Call,day_15_phone_call
out_srcspec_29,,Other source of day 29 information,,,Day 29 Phone Call,day_29_phone_call
out_srcspec_8,,Other source of day 8 information,,,Day 8 Phone Call,day_8_phone_call
out_symp_15___cough,,Which symptoms did the patient report? (choice=Cough),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___ct,,Which symptoms did the patient report? (choice=Chest tightness),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___fever,,Which symptoms did the patient report? (choice=Fever (temperature > 99.5°F with a thermometer)),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___feverish,,Which symptoms did the patient report? (choice=Feeling feverish),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___oth,,Which symptoms did the patient report? (choice=Other),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___sob,,Which symptoms did the patient report? (choice=Shortness of breath),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___st,,Which symptoms did the patient report? (choice=Sore throat),,,Day 15 Phone Call,day_15_phone_call
out_symp_15___weak,,Which symptoms did the patient report? (choice=Weakness or fatigue),,,Day 15 Phone Call,day_15_phone_call
out_symp_29___cough,,Which symptoms did the patient report? (choice=Cough),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___ct,,Which symptoms did the patient report? (choice=Chest tightness),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___fever,,Which symptoms did the patient report? (choice=Fever (temperature > 99.5°F with a thermometer)),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___feverish,,Which symptoms did the patient report? (choice=Feeling feverish),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___oth,,Which symptoms did the patient report? (choice=Other),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___sob,,Which symptoms did the patient report? (choice=Shortness of breath),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___st,,Which symptoms did the patient report? (choice=Sore throat),,,Day 29 Phone Call,day_29_phone_call
out_symp_29___weak,,Which symptoms did the patient report? (choice=Weakness or fatigue),,,Day 29 Phone Call,day_29_phone_call
out_symp_8___cough,,Which symptoms did the patient report? (choice=Cough),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___ct,,Which symptoms did the patient report? (choice=Chest tightness),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___fever,,Which symptoms did the patient report? (choice=Fever (temperature > 99.5°F with a thermometer)),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___feverish,,Which symptoms did the patient report? (choice=Feeling feverish),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___oth,,Which symptoms did the patient report? (choice=Other),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___sob,,Which symptoms did the patient report? (choice=Shortness of breath),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___st,,Which symptoms did the patient report? (choice=Sore throat),,,Day 8 Phone Call,day_8_phone_call
out_symp_8___weak,,Which symptoms did the patient report? (choice=Weakness or fatigue),,,Day 8 Phone Call,day_8_phone_call
out_sympoth_15,,Please specify:,,,Day 15 Phone Call,day_15_phone_call
out_sympoth_29,,Please specify:,,,Day 29 Phone Call,day_29_phone_call
out_sympoth_8,,Please specify:,,,Day 8 Phone Call,day_8_phone_call
out_sympyn_15,,Did the patient report any symptoms on day 15?,,,Day 15 Phone Call,day_15_phone_call
out_sympyn_29,,Did the patient report any symptoms on day 29?,,,Day 29 Phone Call,day_29_phone_call
out_sympyn_8,,Did the patient report any symptoms on day 8?,,,Day 8 Phone Call,day_8_phone_call
out_tm_15,,Time that 15 day assessment was performed,,,Day 15 Phone Call,day_15_phone_call
out_tm_29,,Time that 29 day assessment was performed,,,Day 29 Phone Call,day_29_phone_call
out_tm_8,,Time that 8 day assessment was performed,,,Day 8 Phone Call,day_8_phone_call
pd_ae,,Was an adverse event reported as a result of this deviation?,,,Protocol Deviations,protocol_deviations
pd_desc,,Describe the deviation:,,,Protocol Deviations,protocol_deviations
pd_devdt,,Day deviation occurred:,,,Protocol Deviations,protocol_deviations
pd_devrepdt,,Day deviation discovered:,,,Protocol Deviations,protocol_deviations
pd_devtype,,Type of deviation:,,,Protocol Deviations,protocol_deviations
pd_drugstop,,Was study drug temporarily or permanently discontinued as a result of this deviation?,,,Protocol Deviations,protocol_deviations
pd_drugtype,,Type of drug error:,,,Protocol Deviations,protocol_deviations
pd_other,,Please specify:,,,Protocol Deviations,protocol_deviations
pd_resolution,,Describe steps taken to resolve the deviation and prevent future occurrences:,,,Protocol Deviations,protocol_deviations
pdo_ed,,Did the patient visit an emergency department between discharge from the initial hospitalization and 29 days after randomization?,,,Post-discharge outcomes,postdischarge_outcomes
pdo_eddt,,Day of first emergency department visit:,,,Post-discharge outcomes,postdischarge_outcomes
pdo_oxy,,"Did the patient receive supplemental oxygen between discharge from the initial hospitalization and 29 days after randomization?  Supplemental oxygen is defined as oxygen administered by nasal cannula, face mask, high-flow nasal cannula, non-invasive ventil",,,Post-discharge outcomes,postdischarge_outcomes
pdo_oxydt,,<b><u><I>FINAL</I></u></b> Day receving oxygen between discharge and day 29:,,,Post-discharge outcomes,postdischarge_outcomes
pdo_oxystartdt,,What was the first day on which the patient received oxygen following discharge from the index hospitalization?,,,Post-discharge outcomes,postdischarge_outcomes
pdo_oxystill,,Is the patient still on oxygen at day 29?,,,Post-discharge outcomes,postdischarge_outcomes
pdo_readm,,Did the patient experience hospital readmission between discharge from the initial hospitalization and 29 days after randomization?,,,Post-discharge outcomes,postdischarge_outcomes
pdo_readmdt,,Day of first readmission:,,,Post-discharge outcomes,postdischarge_outcomes
petal_id,Enter the PETAL ID Number,,,,Eligibility Criteria,eligibility_criteria
prmed_azithro,,Azithromycin (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_chlor,,Chloroquine (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_corticoster,,Corticosteroids (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_hydroxychlor,,Hydroxychloroquine (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_interferon,,Interferon  (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_lopinavir,,Lopinavir/ritonavir (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_other,,Other medication(s) between hospital admission and randomization felt to be relevant to trial?,,,Demographics and Enrollment,demographics_and_enrollment
prmed_otherspec,,"If other medication(s), which medication(s)?",,,Demographics and Enrollment,demographics_and_enrollment
prmed_remdesivir,,Remdesivir (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_sarilumab,,Sarilumab (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prmed_tocilizumab,,Tocilizumab (up to randomization),,,Demographics and Enrollment,demographics_and_enrollment
prtrt_conplas,,Convalescent plasma (up to randomization)?,,,Demographics and Enrollment,demographics_and_enrollment
prtrt_immglob,,SARS-CoV-2 hyperimmune globulin (up to randomization)?,,,Demographics and Enrollment,demographics_and_enrollment
prtrt_monocanti,,Monoclonal antibodies (up to randomization)?,,,Demographics and Enrollment,demographics_and_enrollment
r,,,,,Form Unknown,form_unknown
rand_dt,Randomization day,Randomization day,Randomization day,,Randomization,randomization
rand_dt,,Randomization day,Randomization day,,Randomization,randomization
rand_dt,Randomization date and time,Randomization day,Randomization day,,Randomization,randomization
rand_id,What was the patient's randomization number?,,,,Randomization,randomization
rand_order,,,,,Form Unknown,form_unknown
rand_tm,Randomization time,Randomization time,Randomization time,,Form Unknown,form_unknown
rand_tm,,Randomization time,Randomization time,,Form Unknown,form_unknown
rand_trt,Treatment arm,,Treatment arm,,Form Unknown,form_unknown
rand_trt,,,Treatment arm,,Form Unknown,form_unknown
record_id,Record ID,,,,Eligibility Criteria,eligibility_criteria
redcap_data_access_group,Data Access Group,,,,Form Unknown,form_unknown
redcap_repeat_instance,,Repeat Instance,,,Form Unknown,form_unknown
redcap_repeat_instrument,,Repeat Instrument,,,Form Unknown,form_unknown
rxhx_ace,,Does the patient take ACE inhibitors as a home medication?,,,Demographics and Enrollment,demographics_and_enrollment
rxhx_arb,,Does the patient take angiotensin receptor blockers as a home medication?,,,Demographics and Enrollment,demographics_and_enrollment
rxhx_cortico,,Does the patient take corticosteroids as a home medication?,,,Demographics and Enrollment,demographics_and_enrollment
rxhx_nsaids,,Does the patient regularly take non-steroidal anti-inflammatory drugs as a home medication?,,,Demographics and Enrollment,demographics_and_enrollment
safe_aki,,Did the patient have stage II or greater acute kidney injury by KDIGO Criteria between randomization and day 29?Defined as any of the following:Creatinine 2.0-2.9 times baselineIncrease in serum creatinine above 4.0 mg/dlUrine output less than 0.5 ml/kg/h,,,Safety Outcomes,safety_outcomes
safe_akidt,,Day of first meeting criteria for stage II AKI,,,Safety Outcomes,safety_outcomes
safe_anemia,,Did the patient experience hemoglobin < 12.0 g/dL between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_anemiadt,,What was the first day on which the patient experienced anemia?,,,Safety Outcomes,safety_outcomes
safe_astalt,,Did the patient have an aspartate aminotransferase or alanine aminotransferase elevated to at least twice the local upper limit of normal between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_astaltdt,,Day of first elevation of AST or ALT at least twice the local upper limit of normal,,,Safety Outcomes,safety_outcomes
safe_atach,,Did the patient experience atrial tachyarrhythmia between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_atachdt,,Day of first atrial tachyarrhythmia,,,Safety Outcomes,safety_outcomes
safe_ca,,Did the patient experience cardiac arrest between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_cadt,,Day of first cardiac arrest,,,Safety Outcomes,safety_outcomes
safe_caspec,,"Provide a summary of the clinical situation leading to cardiac arrest and the outcome of the cardiac arrest.  Use only deidentified information (i.e. do not provide medical record number or date of birth, and provide study days instead of exact dates).",,,Safety Outcomes,safety_outcomes
safe_derm,,Did the patient experience a severe dermatologic reaction between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_dermdt,,Day dermatologic reaction was first noted?,,,Safety Outcomes,safety_outcomes
safe_hypogly,,Did the patient experience symptomatic hypoglycemia between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_hypoglydt,,Day of first hypoglycemic episode,,,Safety Outcomes,safety_outcomes
safe_lympho,,Did the patient experience absolute lymphocyte count < 1000 (cells/mm3) between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_lymphodt,,What was the first day on which the patient experienced lymphocytopenia?,,,Safety Outcomes,safety_outcomes
safe_neutrop,,Did the patient experience absolute neutrophil count < 1000 (cells/mm3) between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_neutropdt,,What was the first day on which the patient experienced neutropenia?,,,Safety Outcomes,safety_outcomes
safe_pancr,,Did the patient have acute pancreatitis (defined by a clinically obtained lipase level above the local upper limit of normal) between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_pancrdt,,Day of first meeting criteria for acute pancreatitis,,,Safety Outcomes,safety_outcomes
safe_rrtnew,,Did the patient receive new renal replacement therapy between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_rrtnewdt,,Day of first receiving RRT,,,Safety Outcomes,safety_outcomes
safe_seizure,,Did the patient experience seizures between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_seizuredt,,Day of first seizure,,,Safety Outcomes,safety_outcomes
safe_thombo,,Did the patient experience a platelet count < 50 (cell/mm3; in thousands) between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_thombodt,,What was the first day on which the patient experienced thombocytopenia?,,,Safety Outcomes,safety_outcomes
safe_vtach,,Did the patient experience ventricular tachyarrhythmia between randomization and day 29?,,,Safety Outcomes,safety_outcomes
safe_vtachdt,,Day of first ventricular tachyarrhythmia,,,Safety Outcomes,safety_outcomes
safe_vtachspec,,"Provide a summary of the type of ventricular tachycardia (e.g. specific mention of monomorphic or polymorphic ventricular tachycardia or torsades de points in the record), the outcome of event (e.g. did the event require chemical or electrical cardioversio",,,Safety Outcomes,safety_outcomes
scr_m,,,,Month of Screening ,Eligibility Criteria,eligibility_criteria
scr_y,,,,Year of Screening,Eligibility Criteria,eligibility_criteria
site_abbrev,,,,,Form Unknown,form_unknown
sofa_bilih_1,,"Highest bilirubin, mg/dL",,,Demographics and Enrollment,demographics_and_enrollment
sofa_bilih_3,,"Highest bilirubin, mg/dL",,,Day 3 Assessment,day_3_assessment
sofa_creath_1,,"Highest creatinine, mg/dL",,,Demographics and Enrollment,demographics_and_enrollment
sofa_creath_3,,"Highest creatinine, mg/dL",,,Day 3 Assessment,day_3_assessment
sofa_dobut_1,,Dobutamine dose: (mcg/kg/min),,,Demographics and Enrollment,demographics_and_enrollment
sofa_dobut_3,,Dobutamine dose: (mcg/kg/min),,,Day 3 Assessment,day_3_assessment
sofa_dopa_1,,Dopamine dose: (mcg/kg/min),,,Demographics and Enrollment,demographics_and_enrollment
sofa_dopa_3,,Dopamine dose: (mcg/kg/min),,,Day 3 Assessment,day_3_assessment
sofa_epi_1,,Epinephrine dose: (mcg/kg/min),,,Demographics and Enrollment,demographics_and_enrollment
sofa_epi_3,,Epinephrine dose: (mcg/kg/min),,,Day 3 Assessment,day_3_assessment
sofa_gcs_1,,Lowest Glasgow Coma Scale score,,,Demographics and Enrollment,demographics_and_enrollment
sofa_gcs_3,,Lowest Glasgow Coma Scale score,,,Day 3 Assessment,day_3_assessment
sofa_inrh_1,,Highest international normalized ratio (INR),,,Demographics and Enrollment,demographics_and_enrollment
sofa_inrh_3,,Highest international normalized ratio (INR),,,Day 3 Assessment,day_3_assessment
sofa_mapl_1,,"Lowest mean arterial pressure, mmHg",,,Demographics and Enrollment,demographics_and_enrollment
sofa_mapl_3,,"Lowest mean arterial pressure, mmHg",,,Day 3 Assessment,day_3_assessment
sofa_neosyn_1,,Neosynephrine dose: (mcg/kg/min),,,Demographics and Enrollment,demographics_and_enrollment
sofa_neosyn_3,,Neosynephrine dose: (mcg/kg/min),,,Day 3 Assessment,day_3_assessment
sofa_norepi_1,,Norepinephrine dose: (mcg/kg/min),,,Demographics and Enrollment,demographics_and_enrollment
sofa_norepi_3,,Norepinephrine dose: (mcg/kg/min),,,Day 3 Assessment,day_3_assessment
sofa_pao2l_1,,Lowest PaO2,,,Demographics and Enrollment,demographics_and_enrollment
sofa_pao2l_3,,Lowest PaO2,,,Day 3 Assessment,day_3_assessment
sofa_pao2lfio2_1,,"Value for FiO2 at the time of lowest PaO2For patients on nasal cannula, use estimation that FIO2 = 0.21 + 0.03*(LPM of NC O2)",,,Demographics and Enrollment,demographics_and_enrollment
sofa_pao2lfio2_3,,"Value for FiO2 at the time of lowest PaO2For patients on nasal cannula, use estimation that FIO2 = 0.21 + 0.03*(LPM of NC O2)",,,Day 3 Assessment,day_3_assessment
sofa_platl_1,,"Lowest platelet count, per mm3 (in thousands)",,,Demographics and Enrollment,demographics_and_enrollment
sofa_platl_3,,"Lowest platelet count, per mm3 (in thousands)",,,Day 3 Assessment,day_3_assessment
sofa_spo2l_1,,Lowest SpO2,,,Demographics and Enrollment,demographics_and_enrollment
sofa_spo2l_3,,Lowest SpO2,,,Day 3 Assessment,day_3_assessment
sofa_spo2lfio2_1,,"Value for FiO2 at the time of lowest SpO2For patients on nasal cannula, use estimation that FIO2 = 0.21 + 0.03*(LPM of NC O2)",,,Demographics and Enrollment,demographics_and_enrollment
sofa_spo2lfio2_3,,"Value for FiO2 at the time of lowest SpO2For patients on nasal cannula, use estimation that FIO2 = 0.21 + 0.03*(LPM of NC O2)",,,Day 3 Assessment,day_3_assessment
sofa_uout_1,,Urine output (estimated),,,Demographics and Enrollment,demographics_and_enrollment
sofa_uout_3,,Urine output (estimated),,,Day 3 Assessment,day_3_assessment
sofa_vaso_1___dobut,,Which vasopressors did the patient receive in the last 24 hours? (choice=Dobutamine),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vaso_1___dopa,,Which vasopressors did the patient receive in the last 24 hours? (choice=Dopamine),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vaso_1___epi,,Which vasopressors did the patient receive in the last 24 hours? (choice=Epinephrine),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vaso_1___neosyn,,Which vasopressors did the patient receive in the last 24 hours? (choice=Neosynephrine),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vaso_1___norepi,,Which vasopressors did the patient receive in the last 24 hours? (choice=Norepinephrine),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vaso_1___vasop,,Which vasopressors did the patient receive in the last 24 hours? (choice=Vasopressin),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vaso_3___dobut,,Which vasopressors did the patient receive in the last 24 hours? (choice=Dobutamine),,,Day 3 Assessment,day_3_assessment
sofa_vaso_3___dopa,,Which vasopressors did the patient receive in the last 24 hours? (choice=Dopamine),,,Day 3 Assessment,day_3_assessment
sofa_vaso_3___epi,,Which vasopressors did the patient receive in the last 24 hours? (choice=Epinephrine),,,Day 3 Assessment,day_3_assessment
sofa_vaso_3___neosyn,,Which vasopressors did the patient receive in the last 24 hours? (choice=Neosynephrine),,,Day 3 Assessment,day_3_assessment
sofa_vaso_3___norepi,,Which vasopressors did the patient receive in the last 24 hours? (choice=Norepinephrine),,,Day 3 Assessment,day_3_assessment
sofa_vaso_3___vasop,,Which vasopressors did the patient receive in the last 24 hours? (choice=Vasopressin),,,Day 3 Assessment,day_3_assessment
sofa_vasop_1,,Vasopressin dose: (mcg/kg/min),,,Demographics and Enrollment,demographics_and_enrollment
sofa_vasop_3,,Vasopressin dose: (mcg/kg/min),,,Day 3 Assessment,day_3_assessment
sofa_vasoyn_1,,Receipt of vasopressors,,,Demographics and Enrollment,demographics_and_enrollment
sofa_vasoyn_3,,Receipt of vasopressors,,,Day 3 Assessment,day_3_assessment
subject_id,Subject ID,Subject ID,Subject ID,,Form Unknown,form_unknown
subject_id,,Subject ID,Subject ID,,Form Unknown,form_unknown
vit_fio2h_1,,"Highest FiO2For patients on nasal cannula, use estimation that FIO2 = 0.21 + 0.03*(LPM of NC O2)",,,Demographics and Enrollment,demographics_and_enrollment
vit_hrh_1,,"Highest heart rate, bpm",,,Demographics and Enrollment,demographics_and_enrollment
vit_respsup_1,,Respiratory support at enrollment (select one),,,Demographics and Enrollment,demographics_and_enrollment
vit_rrh_1,,"Highest respiratory rate, breaths per minute",,,Demographics and Enrollment,demographics_and_enrollment
vit_spbl_1,,"Lowest systolic blood pressure, mm Hg",,,Demographics and Enrollment,demographics_and_enrollment
vit_spo2l_1,,Lowest SpO2,,,Demographics and Enrollment,demographics_and_enrollment
vit_vasop_1,,Receipt of vasopressors,,,Demographics and Enrollment,demographics_and_enrollment
vs_alivedt,,Last day known to be alive,,,Vital Status,vital_status
vs_deathdt,Day of death,Day of death,Day of death,,Vital Status,vital_status
vs_deathdt,,Day of death,Day of death,,Vital Status,vital_status
vs_deathhosp,,Did the patient die prior to hospital discharge?,,,Vital Status,vital_status
vs_died,,Did the patient die between randomization and study day 29?,,,Vital Status,vital_status
vs_dt,,Day this form was completed,,,Vital Status,vital_status
wd_details,,Details:,,,Patient withdrawal,patient_withdrawal
wd_dt,,Day withdrawn:,,,Patient withdrawal,patient_withdrawal
wd_reas,,Reason for patient withdrawal,,,Patient withdrawal,patient_withdrawal
wd_reas_v2,,Type of study withdrawal:,,,Patient withdrawal,patient_withdrawal
wd_reasspec,,Other reason for patient withdrawal,,,Patient withdrawal,patient_withdrawal
wd_tm,,Time withdrawn:,,,Patient withdrawal,patient_withdrawal
wd_yn,,Did patient withdraw from the study?,,,Patient withdrawal,patient_withdrawal